
INSP Stock Forecast & Price Target
INSP Analyst Ratings
Bulls say
Inspire Medical Systems is in a strong position for long-term growth because of their dominance in the HGNS market and the launch of their next-gen Inspire V device. While their recent financials have been weak due to coding uncertainty and WISeR program impact, management expects a return to revenue growth in 2027 and a recovery in the second half of 2021. Additionally, Inspire's favorable valuation and improved execution potential make them an attractive investment opportunity.
Bears say
Inspire Medical Systems is facing challenges in the short-term due to reimbursement and coding issues, and these issues are likely to affect the company's growth trajectory for the next few quarters. Despite its strong technology and market position, the company is currently facing headwinds that could hinder its ability to ramp up profitability. The company's recent guidance cut and slow growth outlook, coupled with ongoing uncertainties, warrant a more cautious approach to the stock.
This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
INSP Analyst Forecast & Price Prediction
Start investing in INSP
Order type
Buy in
Order amount
Est. shares
0 shares